Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas
- PMID: 301897
Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas
Abstract
Highly purified suspensions of intratumoral T lymphocytes, recovered 11 and 13 days after induction of regressing or progressing Moloney sarcomas, were compared in their ability to lyse specifically the MSC cells used for tumor induction. Cytolytic activity, expressed in terms of lytic units/10(6) T cells, was similar for intratumoral T cell suspensions obtained 11 days after induction of either regressing (3.1 +/- 1.3 LU/10(6) T cells) or progressing (4.3 +/- 1.8) neoplasms. By 13 days post-induction, regressing tumors contained T lymphocytes with an increased cytolytic activity (11.1 +/- 4.5) whereas those from progressing tumors were strikingly less able to kill MSC cells (less than or equal to 0.2). This dramatic loss in cytotoxicity could not be attributed to errors associated with the enzymatic disaggregation method, inhibition by copurified endogenous tumor cells, or immunosuppression induced by viral infection. The changes in functional activity of intratumoral T lymphocytes from the two types of sarcoma appeared to be correlated with the stage of neoplasia. In this model system, cytolytic activity of T lymphocytes increased during spontaneous tumor regression whereas losses in cytotoxicity occurred coincident with the onset of inexorable progression.
Similar articles
-
Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas.J Immunol. 1977 May;118(5):1574-9. J Immunol. 1977. PMID: 870561
-
Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomas.Int J Cancer. 1978 Jan 15;21(1):94-99. doi: 10.1002/ijc.2910210116. Int J Cancer. 1978. PMID: 304846
-
Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.J Natl Cancer Inst. 1978 Sep;61(3):885-90. J Natl Cancer Inst. 1978. PMID: 80457
-
Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression.Int J Cancer. 1976 Sep 15;18(3):331-8. doi: 10.1002/ijc.2910180310. Int J Cancer. 1976. PMID: 1085289
-
Stimulation of tumor cell growth in vitro: a critical evaluation of immunologic specificity.J Natl Cancer Inst. 1977 Sep;59(3):769-74. doi: 10.1093/jnci/59.3.769. J Natl Cancer Inst. 1977. PMID: 70536 Review. No abstract available.
Cited by
-
Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes.J Exp Med. 1979 Jun 1;149(6):1531-6. doi: 10.1084/jem.149.6.1531. J Exp Med. 1979. PMID: 221614 Free PMC article.
-
Mechanisms of tumour rejection in the murine DBA/2-SL2 concomitant immunity system.Cancer Immunol Immunother. 1990;32(3):179-84. doi: 10.1007/BF01771454. Cancer Immunol Immunother. 1990. PMID: 2289212 Free PMC article.
-
Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.Immunology. 1985 Sep;56(1):127-40. Immunology. 1985. PMID: 3876271 Free PMC article.
-
Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo.J Exp Med. 1994 Jan 1;179(1):31-42. doi: 10.1084/jem.179.1.31. J Exp Med. 1994. PMID: 8270874 Free PMC article.
-
Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining Moloney sarcomas.Br J Cancer. 1978 Sep;38(3):365-74. doi: 10.1038/bjc.1978.216. Br J Cancer. 1978. PMID: 81673 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Miscellaneous